Friedenthal Financial’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.13M Buy
+19,427
New +$1.15M 0.49% 40
2025
Q4
– Sell
-29,322
Closed -$1.03M – 302
2025
Q3
$1.03M Buy
+29,322
New +$1.06M 0.53% 43
2025
Q2
– Sell
-2,479
Closed -$77.2K – 307
2025
Q1
$77.2K Buy
+2,479
New +$78.6K 0.05% 128

Other funds holding RPRX

Friedenthal Financial's RPRX Position: Q3 2026 in Review

Friedenthal Financial opened a new position in Royalty Pharma (RPRX) in Q3 2026: 19,427 shares worth $1.13M. The stake represents 0.49% of the portfolio and ranks #40 among its holdings. This is a return to the name: Friedenthal Financial previously reported a position in RPRX as recently as Q3 2025.

Friedenthal Financial first reported a position in RPRX in Q1 2025 and has held it in 3 quarters since. 705 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Friedenthal Financial held 19,427 shares of Royalty Pharma worth $1.13M as of Q3 2026.
  • Royalty Pharma was a new Friedenthal Financial position in Q3 2026.
  • Royalty Pharma made up 0.49% of Friedenthal Financial's portfolio in Q3 2026, its #40 holding.
  • Friedenthal Financial first reported a position in Royalty Pharma in Q1 2025 and has held it in 3 quarters since.
  • 705 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Friedenthal Financial's 13F filing for Q3 2026, filed 27 Oct 2026.